Skip to content

Clinical trials

Terminated Breast Neoplasms trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Terminated Country / region: Bulgaria Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20081
20101
20121
20151
20161
20171
20181
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Aileron Therapeutics, Inc.1
Amgen1
G1 Therapeutics, Inc.1
Gem Pharmaceuticals1
Hoffmann-La Roche1
Intarcia Therapeutics1
NSABP Foundation Inc1
Novartis Pharmaceuticals1
Samsung Bioepis Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms12
Neoplasm Metastasis3
Neoplasms2
Triple Negative Breast Neoplasms2
Alopecia1
Breast Neoplasms, Male1
Carcinoma, Ductal, Breast1
Carcinoma, Lobular1
Carcinoma, Ovarian Epithelial1
Fallopian Tube Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.